Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer

Cooper, David S., Doherty, Gerard M., Haugen, Bryan R., Kloos, Richard T., Lee, Stephanie L., Mandel, Susan J., Mazzaferri, Ernest L., McIver, Bryan +5 more·2009·Thyroid

Cites (614)

Items 401–600 of 696

  1. Ablation of the thyroid remnant and 131I dose in differentiated thyroid cancer
    Suhail A.R. Doi, Nicholas J.Y. Woodhouse · 2000 · Clinical Endocrinology
  2. Suppressive Therapy with Levothyroxine for Solitary Thyroid Nodules: A Double-blind Controlled Clinical Study and Cumulative Meta-analyses
    Flávio Zelmanovitz · 1998 · The Journal of Clinical Endocrinology & Metabolism
  3. Transient hypoparathyroidism following thyroidectomy: A prospective study and multivariate analysis of 604 consecutive patients
    Ottavio Cavicchi, Ottavio Piccin, Umberto Caliceti, Angelo De Cataldis, Renato Pasquali, Alberto Rinaldi Ceroni · 2007 · Otolaryngology
  4. The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET–CT
    Trond Velde Bogsrud, Dimitrios Karantanis, Mark A. Nathan, Brian P. Mullan, Gregory A. Wiseman, Douglas A. Collins, Jan L. Kasperbauer, Scott Eric Strome, Carl C. Reading, IAN D. HAY et al. · 2007 · Nuclear Medicine Communications
  5. Self-stunning in thyroid ablation: evidence from comparative studies of diagnostic 131I and 123I
    TE Hilditch, Mary Frances Dempsey, Alison A. Bolster, Rhona Margaret McMenemin, Nicholas Simon Reed · 2002 · European Journal of Nuclear Medicine and Molecular Imaging
  6. Incidence of Metastatic Well-Differentiated Thyroid Cancer in Cervical Lymph Nodes
    Tracy S. Wang, Sanford Dubner, Laura A. Sznyter, Keith Stuart Heller · 2004 · Archives of Otolaryngology - Head and Neck Surgery
  7. Procedure guideline for radioiodine therapy and 131iodine whole-body scintigraphy in paediatric patients with differentiated thyroid cancer
    Markus Dietlein, Martin Biermann, Michael Christoph Frühwald, Tobias Linden, Peter Bucsky, Christoph Reiners, Otmar Schober, C. Franzius · 2007 · Nuklearmedizin - NuclearMedicine
  8. Tall Cell Variant: An Aggressive Form of Papillary Thyroid Carcinoma
    Stephen Prendiville, Kenneth Dale Burman, Matthew David Ringel, Barry M. Shmookler, Ziad E. Deeb, Katherine Wolfe, Norio Azumi, Leonard Wartofsky, Roy B. Sessions · 2000 · Otolaryngology
  9. Quality of life changes and clinical outcomes in thyroid cancer patients undergoing radioiodine remnant ablation (RRA) with recombinant human TSH (rhTSH): a randomized controlled study
    David Taïeb, Frederic A. Sebag, М. С. Черенько, Karine Baumstarck, Cécile Fortanier, Bardia Farman-Ara, C. De Micco, J. Vaillant, S. Thomas, Bernard Conte‐Devolx et al. · 2008 · Clinical Endocrinology
  10. The Relative Frequency in Which Empiric Dosages of Radioiodine Would Potentially Overtreat or Undertreat Patients Who Have Metastatic Well-Differentiated Thyroid Cancer
    K. Kulkarni, Douglas Van Nostrand, Francis B. Atkins, Matthew Aiken, Kenneth Dale Burman, Leonard Wartofsky · 2006 · Thyroid
  11. The Role of Experience on Judgments of Dysphonia
    Tanya L. Eadie, Mara R. Kapsner-Smith, Juli Rosenzweig, Patricia F. Waugh, Allen Hillel, Albert L. Meratı · 2009 · Journal of Voice
  12. Favourable course of disease after incomplete remission on 131I therapy in children with pulmonary metastases of papillary thyroid carcinoma: 10 years follow-up
    Johannes Biko, Christoph Reiners, Michael Christoph Kreissl, Frederik A. Verburg, Yuri E. Demidchik, Валентина Дрозд · 2010 · European Journal of Nuclear Medicine and Molecular Imaging
  13. Is Diagnostic Iodine-131 Scanning with Recombinant Human TSH Useful in the Follow-Up of Differentiated Thyroid Cancer after Thyroid Ablation?
    Ernest L. Mazzaferri · 2002 · The Journal of Clinical Endocrinology & Metabolism
  14. 131I Therapy for Differentiated Thyroid Cancer Leads to an Earlier Onset of Menopause: Results of a Retrospective Study
    Claudia Ceccarelli, Walter Bencivelli, Donata Morciano, A Pinchera, Furio Pacini · 2001 · The Journal of Clinical Endocrinology & Metabolism
  15. Prognostic importance of various clinicopathological features in papillary thyroid carcinoma
    Lars A. Akslen, Andreas O. Myking, Helga Birgitte Salvesen, Jan Erik Varhaug · 1993 · European Journal of Cancer
  16. Prevalence of Heterophilic Antibody Interference in Eight Automated Tumor Marker Immunoassays
    Carol M. Preissner, Larry A. Dodge, Dennis J. O’Kane, Ravinder Jit Singh, Stefan K. G. Grebe · 2004 · Clinical Chemistry
  17. Clinical Features and Prognostic Factors for Survival in Patients with Poorly Differentiated Thyroid Carcinoma and Comparison to the Patients with the Aggressive Variants of Papillary Thyroid Carcinoma
    Tae Sik Jung, Tae Yong Kim, Kyung Won Kim, Young Lyun Oh, Do Joon Park, Bo Youn Cho, Young Kee Shong, Won Bae Kim, Young Joo Park, Jung Hwa Jung et al. · 2007 · Endocrine Journal
  18. Lack of Impact of Radioiodine Therapy in Tg-Positive, Diagnostic Whole-Body Scan-Negative Patients with Follicular Cell-Derived Thyroid Cancer
    Vahab Fatourechi, IAN D. HAY, Houman Javedan, Gregory A. Wiseman, Brian P. Mullan, Colum A. Gorman · 2002 · The Journal of Clinical Endocrinology & Metabolism
  19. 18F-Fluorodeoxyglucose Positron Emission Tomography Does Not Predict Malignancy in Thyroid Nodules Cytologically Diagnosed as Follicular Neoplasm
    Jung Min Kim, Jin‐Sook Ryu, Tae Yong Kim, Won Bae Kim, Gui Young Kwon, Gyungyub Gong, Dae Hyuk Moon, Seong Chul Kim, Suck Joon Hong, Young Kee Shong · 2007 · The Journal of Clinical Endocrinology & Metabolism
  20. Value of Re-aspirations in Benign Nodular Thyroid Disease
    Murat Faik Erdoğan, Nuri Kamel, DURSUN ARAS, Ali Akdoğan, Nilgün Başkal, Gürbüz Erdoğan · 1998 · Thyroid
  21. Preventable reoperations for persistent and recurrent papillary thyroid carcinoma
    Maria A. Kouvaraki, Jeffrey E. Lee, Suzanne E. Shapiro, Steven I. Sherman, Douglas B. Evans · 2004 · Surgery
  22. Clinical Comparison of Whole-Body Radioiodine Scan and Serum Thyroglobulin After Stimulation with Recombinant Human Thyrotropin
    Bryan R. Haugen, E. Chester Ridgway, Beverly A. McLaughlin, Michael T. McDermott · 2002 · Thyroid
  23. Survival in patients with papillary thyroid cancer is not affected by the use of radioactive isotope
    Yale D. Podnos, David D. Smith, Lawrence David Wagman, Joshua D.I. Ellenhorn · 2007 · Journal of Surgical Oncology
  24. Clinical Characteristics and Outcome of Familial Nonmedullary Thyroid Cancer: A Retrospective Controlled Study
    Eyal Robenshtok, Gloria Tzvetov, Simona Grozinsky‐Glasberg, Ilana Shraga-Slutzky, Ruth Weinstein, Liora Lazar, Svetlana Serov, Joelle Singer, Dania Hirsch, Ilan Shimon et al. · 2010 · Thyroid
  25. Incremental Value of Diagnostic 131I SPECT/CT Fusion Imaging in the Evaluation of Differentiated Thyroid Carcinoma
    Ka Kit Wong, Natalia Zarzhevsky, John M. Cahill, Kirk A. Frey, Anca M. Avram · 2008 · American Journal of Roentgenology
  26. Completion thyroidectomy in patients with thyroid cancer who initially underwent unilateral operation
    Eun Sook Kim, Tae Yong Kim, Jung Min Koh, Young Il Kim, Suck Joon Hong, Won Bae Kim, Young Kee Shong · 2004 · Clinical Endocrinology
  27. Solitary Thyroid Nodules in 93 Children and Adolescents
    Wellington Hung · 1999 · Hormone Research in Paediatrics
  28. Encapsulated Columnar-cell Neoplasms of the Thyroid
    Harry L. Evans · 1996 · The American Journal of Surgical Pathology
  29. Low-activity (2.0 GBq; 54 mCi) radioiodine post-surgical remnant ablation in thyroid cancer: comparison between hormone withdrawal and use of rhTSH in low-risk patients
    Marco Chianelli, Valerio Todino, Filomena Maria Graziano, Chiara Panunzi, D Pace, Rinaldo Guglielmi, Alberto Signore, Enrico Papini · 2008 · European Journal of Endocrinology
  30. Controversies in the Surgical Management of Newly Diagnosed and Recurrent/Residual Thyroid Cancer
    Rebecca S. Sippel, Herbert Chen · 2009 · Thyroid
  31. The Utility of Radioiodine Scans Prior to Iodine 131 Ablation in Patients with Well-Differentiated Thyroid Cancer
    Douglas Van Nostrand, Martha Aiken, Frank Atkins, Shari Moreau, Carlos Garcia, Elmo Acio, Kenneth Dale Burman, Leonard Wartofsky · 2009 · Thyroid
  32. Histological Aggressiveness of Fluorodeoxyglucose Positron-Emission Tomogram (FDG-PET)-Detected Incidental Thyroid Carcinomas
    Chandrakanth Are, John F. Hsu, Ronald A. Ghossein, Heiko M. Schöder, Jatin P. Shah, Ashok R. Shaha · 2007 · Annals of Surgical Oncology
  33. Management of Thyroid Nodules in Pregnancy
    Gerry H. Tan · 1996 · Archives of Internal Medicine
  34. Lithium as a Potential Adjuvant to 131I Therapy of Metastatic, Well Differentiated Thyroid Carcinoma
    S.-S. Koong · 1999 · The Journal of Clinical Endocrinology & Metabolism
  35. Cytotoxic Effects of Carboplatinum and Epirubicin in the Setting of an Elevated Serum Thyrotropin for Advanced Poorly Differentiated Thyroid Cancer
    Ferruccio Santini, Valeria Bottici, Rossella Elisei, Lucia Montanelli, Salvatore Mazzeo, Fulvio Basolo, Aldo Pinchera, Furio Pacini · 2002 · The Journal of Clinical Endocrinology & Metabolism
  36. Beyond the Suspicious Thyroid Fine Needle Aspirate
    Dorry Lidor Segev, Douglas P. Clark, Martha A. Zeiger, Christopher B. Umbricht · 2003 · Acta Cytologica
  37. Encapsulated thyroid tumors of follicular cell origin with high grade features (high mitotic rate/tumor necrosis): a clinicopathologic and molecular study
    Michael Rivera, Julio C. Ricarte‐Filho, Snehal G. Patel, Michael R. Tuttle, Ashok R. Shaha, Jatin P. Shah, James A. Fagin, Ronald A. Ghossein · 2009 · Human Pathology
  38. Molecular, Morphologic, and Outcome Analysis of Thyroid Carcinomas According to Degree of Extrathyroid Extension
    Michael Rivera, Julio C. Ricarte‐Filho, Robert Michael Tuttle, Ian Ganly, Ashok R. Shaha, Jeffrey A. Knauf, James A. Fagin, Ronald A. Ghossein · 2010 · Thyroid
  39. Ablation of Skeletal Metastases: Current Status
    A. Nicholas Kurup, Matthew R. Callstrom · 2010 · Journal of Vascular and Interventional Radiology
  40. Dietary Iodine Restriction in Preparation for Radioactive Iodine Treatment or Scanning in Well-Differentiated Thyroid Cancer: A Systematic Review
    Anna M. Sawka, Irada Ibrahim-zada, Philip Galacgac, Richard W. C. Tsang, James D. Brierley, Shereen Ezzat, David Paul Goldstein · 2010 · Thyroid
  41. Clinical relevance of highly sensitive Tg assay in monitoring patients treated for differentiated thyroid cancer
    Annalisa Iervasi, Giorgio Iervasi, Marco Ferdeghini, C. Solimeo, Antonio Bottoni, Leonardo Rossi, Chiara Colato, G.C. Zucchelli · 2007 · Clinical Endocrinology
  42. Quality Assurance in Molecular Genetic Testing Laboratories
    Margaret M. McGovern · 1999 · JAMA
  43. Recurrent/metastatic thyroid carcinomas false negative for serum thyroglobulin but positive by posttherapy I-131 whole body scans
    Eunkyung Park, June-Key Chung, Il Han Lim, Do Joon Park, Dong Soo Lee, Myung Chul Lee, Bo Youn Cho · 2008 · European Journal of Nuclear Medicine and Molecular Imaging
  44. Follow-Up of Low-Risk Differentiated Thyroid Cancer Patients Who Underwent Radioiodine Ablation of Postsurgical Thyroid Remnants after Either Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal
    Rossella Elisei, Martin Jean Schlumberger, A. A. Driedger, Christoph Reiners, Richard T. Kloos, Steven I. Sherman, Bryan R. Haugen, C. Corone, Eleonora Molinaro, Lucia Grasso et al. · 2009 · The Journal of Clinical Endocrinology & Metabolism
  45. The Nonimpact of Thyroid Stunning: Remnant Ablation Rates in 131I-Scanned and Nonscanned Individuals
    Lilah F. Morris, Alan D. Waxman, Glenn David Braunstein · 2001 · The Journal of Clinical Endocrinology & Metabolism
  46. Differentiated thyroid cancer long-term impact of initial therapy.
    Ernest L. Mazzaferri, Sissy Meihua Jhiang · 1995 · PubMed
  47. Safety of Modified Radical Neck Dissection for Differentiated Thyroid Carcinoma
    Michael Elliot Kupferman, D. Michael Patterson, Susan J. Mandel, Virginia A. LiVolsi, Randal S. Weber · 2004 · The Laryngoscope
  48. Towards improving the utility of fine‐needle aspiration biopsy for the diagnosis of thyroid tumours
    Bryan R. Haugen, Whitney W. Woodmansee, Michael T. McDermott · 2002 · Clinical Endocrinology
  49. Risk of second primary cancer following differentiated thyroid cancer
    Emmanuelle Berthe, Michel Henry-Amar, Jean-Jacques Michels, Jean-Pierre Rame, Pascaline Berthet, E. Babin, Philippe Icard, Guy Samama, Françoise Galateau-Sallé, JACQUES A. MAHOUDEAU et al. · 2004 · European Journal of Nuclear Medicine and Molecular Imaging
  50. Radioiodine Therapy for Thyroid Cancer and Hyperthyroidism in Patients with End-Stage Renal Disease on Hemodialysis
    Jennifer P. Holst, Kenneth Dale Burman, Frank Atkins, Jason G. Umans, Jacqueline Jonklaas · 2005 · Thyroid
  51. Diagnostic Accuracy of 18F-Fluorodeoxyglucose Positron Emission Tomography in the Follow-Up of Papillary or Follicular Thyroid Cancer
    Lotty Hooft, Otto S. Hoekstra, W.L.J.M. Devillé, Paul T.A.M. Lips, Gerrit J. J. Teule, Maarten Boers, Maurits W. van Tulder · 2001 · The Journal of Clinical Endocrinology & Metabolism
  52. The follow-up of patients with differentiated thyroid cancer and undetectable thyroglobulin (Tg) and Tg antibodies during ablation
    Ha T.T. Phan, Pieter L. Jager, Jacqueline E. van der Wal, Wim J. Sluiter, John Th. M. Plukker, Rudi Dierckx, Bruce H. R. Wolffenbuttel, Thera P. Links · 2008 · European Journal of Endocrinology
  53. Management of Low-Risk Well-Differentiated Thyroid Cancer Based Only on Thyroglobulin Measurement After Recombinant Human Thyrotropin
    Leonard Wartofsky · 2002 · Thyroid
  54. Application of post‐surgical stimulated thyroglobulin for radioiodine remnant ablation selection in low‐risk papillary thyroid carcinoma
    Alon Vaisman, Steven Orlov, Jonathan Yip, Cindy Hu, Terence Lim, Mark Dowar, Jeremy L. Freeman, Paul G. Walfish · 2010 · Head & Neck
  55. Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in Preoperative Assessment of Cytologically Indeterminate Thyroid Nodules
    Fernando Moreno Sebastianes, Juliano J. Cerci, Patrícia H. Zanoni, José Soares, L. K Chibana, Eduardo Kiyoshi Tomimori, R. Y. A. Camargo, Marisa Izaki, Maria Clementina Pinto Giorgi, José Eluf‐Neto et al. · 2007 · The Journal of Clinical Endocrinology & Metabolism
  56. Comparison of completion thyroidectomy and primary surgery for differentiated thyroid carcinoma
    Ergün Erdem, Mehmet Ali Gülçelik, Bekir Kuru, Haluk Alagöl · 2003 · European Journal of Surgical Oncology
  57. Pretherapeutic Staging of Hypopharyngeal Carcinoma: Clinical Findings, Computed Tomography, and Magnetic Resonance Imaging Compared With Histopathologic Evaluation
    Peter Zbären, Minerva Becker, Hubert Läng · 1997 · Archives of Otolaryngology - Head and Neck Surgery
  58. Factors Influencing the Basal and Recombinant Human Thyrotropin-Stimulated Serum Thyroglobulin in Patients with Metastatic Thyroid Carcinoma
    Richard J. Robbins, Shefali Srivastava, Ashok R. Shaha, Ronald A. Ghossein, Steven M. Larson, Martin Fleisher, Robert Michael Tuttle · 2004 · The Journal of Clinical Endocrinology & Metabolism
  59. Sudden Enlargement of Local Recurrent Thyroid Tumor after Recombinant Human TSH Administration
    Milena Braga, Matthew David Ringel, David S. Cooper · 2001 · The Journal of Clinical Endocrinology & Metabolism
  60. The dynamics of serum thyroglobulin elimination from the body after thyroid surgery
    Marko Hočevar, M. Auersperg, L. Stanovnik · 1997 · European Journal of Surgical Oncology
  61. Psychosocial and physical correlates of survival and recurrence in patients with head and neck carcinoma
    Maarten F. de Boer, Bart H.P. van den Borne, Jean F. A. Pruyn, Richard M. Ryckman, Lex Volovics, Paul P. M. Knegt, Cees A. Meeuwis, Ilse Mesters, Carel D. A. Verwoerd · 1998 · Cancer
  62. Comparison of iodine uptake in tumour and nontumour tissue under thyroid hormone deprivation and with recombinant human thyrotropin in thyroid cancer patients
    Christian Pötzi, Abbas Moameni, Georgios Karanikas, J. Preitfellner, Alexander Becherer, Christian Pirich, Robert Dudczak · 2006 · Clinical Endocrinology
  63. Prognosis and Treatment of Brain Metastases in Thyroid Carcinoma
    A. C. Chiu · 1997 · The Journal of Clinical Endocrinology & Metabolism
  64. The Use of Preoperative Routine Measurement of Basal Serum Thyrocalcitonin in Candidates for Thyroidectomy due to Nodular Thyroid Disorders: Results from 2733 Consecutive Patients
    Guillaume Chambon, Caroline Alovisetti, Catherine Idoux-Louche, Christophe Reynaud, Michel Rodier, A.M. Guedj, Héliette Chapuis, Jean‐Gabriel Lallemant, Benjamin Lallemant · 2010 · The Journal of Clinical Endocrinology & Metabolism
  65. Papillary Thyroid Carcinomas with Lung Metastases
    Jen‐Der Lin, Tzu‐Chieh Chao, Shuo-Chi Chou, Chuen Hsueh · 2004 · Thyroid
  66. Radioactive Iodine Lobe Ablation as an Alternative to Completion Thyroidectomy for Follicular Carcinoma of the Thyroid
    Gregory William Randolph, Gilbert H. Daniels · 2002 · Thyroid
  67. Fine needle aspiration biopsy of thyroid nodules
    İrfan Serdar Arda · 2001 · Archives of Disease in Childhood
  68. Embolization in combination with radioiodine therapy for bone metastases from differentiated thyroid carcinoma
    Karin M. van Tol, J. M. Hew, P. L. Jager, A Vermey, Robin P. F. Dullaart, Thera P. Links · 2000 · Clinical Endocrinology
  69. Thyrotropin Suppressive Therapy in Thyroid Carcinoma: What Are the Targets?
    Georg E. Brabant · 2008 · The Journal of Clinical Endocrinology & Metabolism
  70. The BRAFT1796A transversion is a prevalent mutational event in human thyroid microcarcinoma
    Ilya Sedliarou, Vladimir Saenko, Dmitry Lantsov, Tatiana Rogounovitch, Hiroyuki Namba, Aleksandr Abrosimov, Eugeny F. Lushnikov, Atsushi Kumagai, Masahiro Nakashima, Serik K. Meirmanov et al. · 2004 · International Journal of Oncology
  71. Clinical Trials for Progressive Differentiated Thyroid Cancer: Patient Selection, Study Design, and Recent Advances
    Martin Jean Schlumberger, Steven I. Sherman · 2009 · Thyroid
  72. Tracheal Invasion by Thyroid Carcinoma
    Jichen Wang, Shodayu Takashima, Fumiyoshi Takayama, Satoshi Kawakami, Akitoshi Saito, Tsuyoshi Matsushita, Hideki Matsuba, Shinya Kobayashi · 2001 · American Journal of Roentgenology
  73. Post I-131 Therapy Scanning in Patients With Thyroid Carcinoma Metastases: An Unnecessary Cost or a Relevant Contribution?
    Pedro Weslley Rosário, Álvaro Luís Barroso, Leonardo Lamego Rezende, Eduardo Lanza Padrao, Tales Alvarenga Fagundes, Gustavo Penna, Saulo Purisch · 2004 · Clinical Nuclear Medicine
  74. External Beam Radiotherapy in the Management of Differentiated Thyroid Cancer
    Daniel Ford, Selvaraj Giridharan, Chris McConkey, Andrew G. J. Hartley, Caroline Brammer, John C Watkinson, John Glaholm · 2003 · Clinical Oncology
  75. Radioiodine in the Treatment of Thyroid Cancer
    Douglas Van Nostrand, Leonard Wartofsky · 2007 · Endocrinology and Metabolism Clinics of North America
  76. Effects of therapeutic doses of 131I in thyroid papillary carcinoma patients with elevated thyroglobulin level and negative 131I whole‐body scan: comparative study
    Jung‐Min Koh, Eun Sook Kim, Jin Sook Ryu, Suck Joon Hong, Won Bae Kim, Young Kee Shong · 2003 · Clinical Endocrinology
  77. Handling of Thyroid Follicular Patterned Lesions
    Juan Rosaí · 2005 · Endocrine Pathology
  78. Iodine-131 treatment and high-resolution CT: results in patients with lung metastases from differentiated thyroid carcinoma
    Seyfettin Ilgan, Alper Özgür Karaçalıoğlu, Gökçe Kaan Ataç, Nuri Arslan, Emel Öztürk, Bengül Günalp, Mehmet Özgüven, Yüksel Pabuşçu · 2004 · European Journal of Nuclear Medicine and Molecular Imaging
  79. Dosimetry-guided high-activity 131I therapy in patients with advanced differentiated thyroid carcinoma: initial experience
    Frederik A. Verburg, Heribert Hänscheid, Johannes Biko, Maria Hategan, Michael Laßmann, Michael Christoph Kreissl, Christoph Reiners, Markus Luster · 2009 · European Journal of Nuclear Medicine and Molecular Imaging
  80. SERIAL SERUM THYROGLOBULIN MEASUREMENTS IN THE MANAGEMENT OF DIFFERENTIATED THYROID CARCINOMA
    E. G. Black, Michael C. Sheppard, R Hoffenberg · 1987 · Clinical Endocrinology
  81. The Dental Safety Profile of High-Dose Radioiodine Therapy for Thyroid Cancer: Long-Term Results of a Longitudinal Cohort Study
    Martin Alexander Walter, Christian P. Turtschi, Christian J. A. Schindler, Peter Minnig, Jan Müller‐Brand, Beat Peter Müller-Stich · 2007 · Journal of Nuclear Medicine
  82. The Impact of Thyroid Cancer and Post-Surgical Radioactive Iodine Treatment on the Lives of Thyroid Cancer Survivors: A Qualitative Study
    Anna M. Sawka, David Paul Goldstein, James D. Brierley, Richard W. C. Tsang, LORNE E. ROTSTEIN, Shereen Ezzat, Sharon Elizabeth Straus, Susan R. George, Susan E Abbey, Gary Rodin et al. · 2009 · PLoS ONE
  83. Positron emission tomography in thyroid cancer management
    Steven M. Larson, Richard J. Robbins · 2002 · Seminars in Roentgenology
  84. Circulating Thyrotropin Receptor mRNA as a Novel Marker of Thyroid Cancer
    Mira Milas, Joyce Shin, Manjula K. Gupta, Tomislav Novosel, Christian E. Nasr, Jennifer Brainard, Jamie C. Mitchell, Eren Berber, ALLAN E. SIPERSTEIN · 2010 · Annals of Surgery
  85. The influence of saliva flow stimulation on the absorbed radiation dose to the salivary glands during radioiodine therapy of thyroid cancer using 124I PET(/CT) imaging
    Jentzen, Walter, Balschuweit, Dorothee, Schmitz, Jochen, Freudenberg, Lutz, Eising, Ernst, Hilbel, Thomas, Bockisch, Andreas, Stahl, Alexander · 2010 · European Journal of Nuclear Medicine and Molecular Imaging
  86. Value of external irradiation for locally advanced papillary thyroid cancer
    Tae Hyun Kim, Dae Sik Yang, Kwang‐Yoon Jung, Chul Yong Kim, Myung-Sun Choi · 2003 · International Journal of Radiation Oncology*Biology*Physics
  87. Invasive differentiated thyroid carcinoma: Tracheal resection and reconstruction procedures in the hands of the endocrine surgeon
    Thomas J. Musholt, Petra B. Musholt, Matthias Behrend, Rudolf Raab, Georg F. W. Scheumann, Jurgen L. Klempnauer · 1999 · Surgery
  88. Sonographic Differentiation of Partially Cystic Thyroid Nodules: A Prospective Study
    Dong Wook Kim, E.J. Lee, Hyun Sin In, S.J. Kim · 2010 · American Journal of Neuroradiology
  89. Outcome in patients with differentiated thyroid cancer with negative diagnostic whole-body scanning and detectable stimulated thyroglobulin
    Karin M. van Tol, P.L. Jager, Elisabeth G.E. de Vries, DA Piers, HM Boezen, W.J. Sluiter, Robin P. F. Dullaart, TP Links · 2003 · European Journal of Endocrinology
  90. Phase II Trial of Thalidomide for Therapy of Radioiodine-Unresponsive and Rapidly Progressive Thyroid Carcinomas
    Kenneth B. Ain, Charles Lee, Kevin D. Williams · 2007 · Thyroid
  91. Comparison of Outcomes After 123I Versus 131I Preablation Imaging Before Radioiodine Ablation in Differentiated Thyroid Carcinoma
    Edward B. Silberstein · 2007 · Journal of Nuclear Medicine
  92. Hemiplegia after Thyrotropin Alfa in a Hypothyroid Patient with Thyroid Carcinoma Metastatic to the Brain
    George E. Vargas, Harry L. Uy, Carlos Bazan, Theresa A. Guise, Jan Bruder · 1999 · The Journal of Clinical Endocrinology & Metabolism
  93. I-123 Diagnostic Thyroid Tumor Whole-Body Scanning with Imaging at 6, 24, and 48 Hours
    Stephen K. Gerard, Ralph R. Cavalieri · 2002 · Clinical Nuclear Medicine
  94. Thyroid Isthmusectomy for Well-Differentiated Thyroid Cancer
    Iain James Nixon, Frank L. Palmer, Monica M. Whitcher, Ashok R. Shaha, Jatin P. Shah, Snehal G. Patel, Ian Ganly · 2010 · Annals of Surgical Oncology
  95. Solitary thyroid nodule
    Ernest L. Mazzaferri · 1981 · Postgraduate Medicine
  96. Diagnostic and therapeutic strategies for minimally and widely invasive follicular thyroid carcinomas
    Chao-Chun Huang, Chuen Hsueh, Feng-Hsuan Liu, Tzu‐Chieh Chao, Jen‐Der Lin · 2009 · Surgical Oncology
  97. Lithium as an Adjuvant of lodine-131 Uptake when Treating Patients with Well-Differentiated Thyroid Carcinoma
    Francisca Pons, Ignasi Carri�, Montserrat Estorch, M. Ginjaume, J PONS, René Llapur Milián · 1987 · Clinical Nuclear Medicine
  98. Lack of Association between Urinary Iodine Excretion and Successful Thyroid Ablation in Thyroid Cancer Patients
    Hernán Tala, Maria Grazia Castagna, Carla Fioravanti, Claudia Cipri, Ernesto Brianzoni, Furio Pacini · 2009 · The Journal of Clinical Endocrinology & Metabolism
  99. Serum Thyrotropin (TSH) Levels after Thyroid Ablation Compared with TSH Levels after Exogenous Bovine TSH: Implications for131I Treatment of Thyroid Carcinoma
    Jerome M. Hershman, C. LOWELL EDWARDS · 1972 · The Journal of Clinical Endocrinology & Metabolism
  100. THE URINARY EXCRETION AND THYROID UPTAKE OF IODINE IN RENAL DISEASE 1
    William F. Perry, John F. S. Hughes · 1952 · Journal of Clinical Investigation
  101. Value of Post-Therapy Whole-Body I-131 Imaging in the Evaluation of Patients with Thyroid Carcinoma Having Undergone High-Dose I-131 Therapy
    William G. Spies, CONSTANCE H. WOJTOWICZ, STEWART M. SPIES, ALKA Y. SHAH, Aline Zimmer · 1989 · Clinical Nuclear Medicine
  102. Detection of Thyrotropin-Receptor Messenger Ribonucleic Acid (mRNA) and Thyroglobulin mRNA Transcripts in Peripheral Blood of Patients with Thyroid Disease: Sensitive and Specific Markers for Thyroid Cancer
    Priya Chinnappa, Leslie Taguba, Rosemarie Arciaga, Charles Faiman, ALLAN E. SIPERSTEIN, Adi Mehta, Sethu K. Reddy, Christian E. Nasr, Manjula K. Gupta · 2004 · The Journal of Clinical Endocrinology & Metabolism
  103. Treatment of Scan-Negative, Thyroglobulin-Positive Metastatic Thyroid Cancer Using Radioiodine131I and Recombinant Human Thyroid Stimulating Hormone
    Amiel Z. Rudavsky, Leonărd M. Freeman · 1997 · The Journal of Clinical Endocrinology & Metabolism
  104. Post-ablative serum thyroglobulin is an independent predictor of recurrence in low-risk differentiated thyroid carcinoma: a 16-year follow-up study
    Hanna Pelttari, Matti J. Välimäki, Eliisa Löyttyniemi, Camilla Schalin‐Jäntti · 2010 · European Journal of Endocrinology
  105. High or low dose radioiodine ablation of thyroid remnants?
    Hans Creutzig · 1987 · European Journal of Nuclear Medicine and Molecular Imaging
  106. Implication of vascular endothelial growth factor and p53 status for angiogenesis in noninvasive colorectal carcinoma
    Yoko Kondo, Shigeki Arii, Masaharu Furutani, Shun‐Ichi Isigami, Akira Mori, Hisashi Onodera, Tsutomu Chiba, Masayuki Imamura · 2000 · Cancer
  107. Predicting the efficacy of first iodine-131 treatment in differentiated thyroid carcinoma.
    J P Muratet, P. Giraud, Alain Daver, J.F. Minier, Erick C. Gamelin, F Larra · 1997 · PubMed
  108. Use of Radioactive Iodine for Thyroid Remnant Ablation in Well-Differentiated Thyroid Carcinoma to Replace Thyroid Reoperation
    Jui‐Hsiang Lin, Tzu‐Chieh Chao, M. J. Huang, Hsiao‐Fen Weng, Kai‐Yuan Tzen · 1998 · American Journal of Clinical Oncology
  109. Rehospitalization among Elderly Patients with Thyroid Cancer after Thyroidectomy are Prevalent and Costly
    Charles T. Tuggle, Lesley S. Park, Sanziana A. Roman, Robert Udelsman, Julie Ann Sosa · 2010 · Annals of Surgical Oncology
  110. Role of prophylactic central neck dissection in cN0 papillary thyroid cancer.
    S Costa, Gioacchino Giugliano, Luigi Santoro, André Ywata de Carvalho, Maria Angela Massaro, Bianca Gibelli, Elvio De Fiori, Enrica Grosso, Mohssen Ansarin, Luca Salvatore Calabrese · 2009 · PubMed Central
  111. Clinical and Cytological Features Predictive of Malignancy in Thyroid Follicular Neoplasms
    Carrie Cunningham Lubitz, William C. Faquin, Jingyun Yang, Michal Mekel, Randall D. Gaz, Sareh Parangi, Gregory William Randolph, Richard A. Hodin, Antonia E. Stephen · 2009 · Thyroid
  112. Predictive Value of Sonographic Features in Preoperative Evaluation of Malignant Thyroid Nodules in a Multinodular Goiter
    Artür Salmaslıoğlu, Yeşim Erbil, Ahmet Cem Dural, Halim İşsever, Yersu Kapran, Selçuk Özarmağan, Serdar Tezelman · 2008 · World Journal of Surgery
  113. Radiofrequency ablation of bony metastatic disease
    Anthony Posteraro, Damian Edward Dupuy, William W. Mayo-Smith · 2004 · Clinical Radiology
  114. Predicting Outcome and Directing Therapy for Papillary Thyroid Carcinoma
    Sendia Kim · 2004 · Archives of Surgery
  115. Thyroid Cancer Recurrence in Patients Clinically Free of Disease with Undetectable or Very Low Serum Thyroglobulin Values
    Richard T. Kloos · 2010 · The Journal of Clinical Endocrinology & Metabolism
  116. Medullary Thyroid Cancer: Are Practice Patterns in the United States Discordant From American Thyroid Association Guidelines?
    Babita Panigrahi, Sanziana A. Roman, Julie Ann Sosa · 2010 · Annals of Surgical Oncology
  117. Medical management of thyroid cancer: a risk adapted approach
    Robert Michael Tuttle, Rébecca Leboeuf, Ashok R. Shaha · 2008 · Journal of Surgical Oncology
  118. Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi
    Aleksandra Kukulska, Jolanta Krajewska, Marzena Gawkowska‐Suwińska, Zbigniew Puch, Ewa Paliczka-Cieślik, Józef Roskosz, Daria Handkiewicz-Junak, Michał Jarząb, Elżbieta Gubała, Barbara Jarząb · 2010 · Thyroid Research
  119. Radioactive Iodine Administered for Thyroid Remnant Ablation Following Recombinant Human Thyroid Stimulating Hormone Preparation Also Has an Important Adjuvant Therapy Function
    Robert Michael Tuttle, Norma Lopez, Rébecca Leboeuf, Shaye M. Minkowitz, Ravinder K. Grewal, Matvey Brokhin, Gal Omry, Steven M. Larson · 2010 · Thyroid
  120. Clinicopathologic Characteristics and Prognosis of Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma in Japan: An 18‐Year Experience at a Single Institution
    Mitsuhiro Fukushima, Yasuhiro Ito, Mitsuyoshi Hirokawa, Haruki Akasu, Kazuo Shimizu, Akira Miyauchi · 2009 · World Journal of Surgery
  121. Low Specificity of Blood Thyroglobulin Messenger Ribonucleic Acid Assay Prevents Its Use in the Follow-Up of Differentiated Thyroid Cancer Patients
    Rossella Elisei, Agnese Vivaldi, Laura Agate, Eleonora Molinaro, Chiara Nencetti, Lucia Grasso, Aldo Pinchera, Furio Pacini · 2004 · The Journal of Clinical Endocrinology & Metabolism
  122. Thyroid Nodular Disease in Pregnancy: Current Diagnosis and Management
    Irving B. Rosen, MARK KORMAN, Paul G. Walfish · 1997 · Clinical Obstetrics & Gynecology
  123. Nonmelanoma skin carcinoma in Albuquerque, New Mexico: Experience of a major health care provider
    Wendy E. Hoy · 1996 · Cancer
  124. Lithium as adjuvant to radioiodine therapy in differentiated thyroid carcinoma: clinical and in vitro studies
    Y.Y. Liu, Gabri van der Pluijm, Marcel Karperien, Marcel P. M. Stokkel, Alberto M. Pereira, J. Morreau, Job Kievit, Johannes Anthonius Romijn, Johannes W. A. Smit · 2006 · Clinical Endocrinology
  125. Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer
    N. Lima, Humberto Cavaliere, Eduardo Kiyoshi Tomimori, Meyer Knobel, Geraldo A. Medeiros-Neto · 2002 · Journal of Endocrinological Investigation
  126. Predictive Value of Serum Thyroglobulin After Surgery for Thyroid Carcinoma
    Francis T. Hall, Nigel J P Beasley, Spiro J. Eski, Ian Witterick, Paul G. Walfish, Jeremy L. Freeman · 2003 · The Laryngoscope
  127. Moderate Hypothyroidism in Preparation for Whole Body 131 I Scintiscans and Thyroglobulin Testing
    Valéria C. Guimarães, Leslie J. DeGroot · 1996 · Thyroid
  128. Rapid Rise in Serum Thyrotropin Concentrations after Thyroidectomy or Withdrawal of Suppressive Thyroxine Therapy in Preparation for Radioactive Iodine Administration to Patients with Differentiated Thyroid Cancer
    Dina I. Serhal, Mona Nasrallah, Baha M. Arafah · 2004 · The Journal of Clinical Endocrinology & Metabolism
  129. Benign thyroid disease and vocal cord palsy.
    Julian Rowe‐Jones, R P Rosswick, S. E. J. Leighton · 1993 · PubMed
  130. Serum thyroglobulin concentrations and (131)I whole-body scan results in patients with differentiated thyroid carcinoma after administration of recombinant human thyroid-stimulating hormone.
    Alessia David, Annabella Blotta, Marta Bondanelli, R Rossi, E. Roti, Lewis E. Braverman, Luciano Busutti, Ettore C. degli Uberti · 2001 · PubMed
  131. Compassionate Use of Recombinant Human Thyrotropin to Facilitate Radioiodine Therapy: Case Report and Review of Literature
    Richard J. Robbins, Emily Voelker, Weiping Wang, Homer A. Macapinlac, Steven M. Larson · 2000 · Endocrine Practice
  132. Efficacy of low and high 131I doses for thyroid remnant ablation in patients with differentiated thyroid carcinoma based on post-operative cervical uptake
    Pedro Weslley Rosário, Janice Sepúlveda Reis, Álvaro Luís Barroso, Leonardo Lamego Rezende, Eduardo Lanza Padrao, Tales Alvarenga Fagundes · 2004 · Nuclear Medicine Communications
  133. Neck recurrence from thyroid carcinoma: serum thyroglobulin and high‐dose total body scan are not reliable criteria for cure after radioiodine treatment
    Anne Bachelot, Sophie Leboulleux, Éric Baudin, Dana M. Hartl, Bernard Caillou, Jean‐Paul Travagli, Martin Jean Schlumberger · 2005 · Clinical Endocrinology
  134. Antithyroglobulin antibodies in patients with differentiated thyroid carcinoma: methods of detection, interference with serum thyroglobulin measurement and clinical significance
    Pedro Weslley Rosário, Frederico Fernandes Ribeiro Maia, Tales Alvarenga Fagundes, Flávio P.J. Vasconcelos, Ludmilla David Cardoso, Saulo Purisch · 2004 · Arquivos Brasileiros de Endocrinologia & Metabologia
  135. Thyroid fine needle aspiration cytology: a review of the National Cancer Institute state of the science symposium
    Lester James Layfield, Edmund S. Cibas, Zubair Wahid Baloch · 2010 · Cytopathology
  136. Molecular Markers in Thyroid Fine-needle Aspiration Biopsy
    Carmen Franco, Virginia Martínez, J Allamand, Francisco Medina, Andrea Glasinovic P., Miren Osorio, Dina Schächter · 2009 · Applied immunohistochemistry & molecular morphology
  137. The Locality Rule and the Physician's Dilemma
    Michelle Lewis, John K. Gohagan, Daniel J. Merenstein · 2007 · JAMA
  138. Role of metastasectomy in the management of thyroid carcinoma: The NIH experience
    Ho Pak, Loukas Gourgiotis, Wen‐I Chang, Lori C. Guthrie, Monica C. Skarulis, James C. Reynolds, Maria J. Merino, David S. Schrump, Steven K. Libutti, Henry Richard Alexander et al. · 2002 · Journal of Surgical Oncology
  139. The Rate of Tumour Growth Does Not Distinguish Between Malignant and Benign Thyroid Nodules
    Shinya Kobayashi Kazuhiko Asanuma · 2001 · The European Journal of Surgery
  140. Is there a role for fluorodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules?
    Nathan W. Hales, Greg A. Krempl, Jesús E. Medina · 2008 · American Journal of Otolaryngology
  141. Influence of surgical and postoperative treatment on survival in differentiated thyroid cancer
    Catharina Ihre Lundgren, Per N Hall, Paul William Dickman, Jan Zedenius · 2007 · British journal of surgery
  142. Individualized dosimetry in the management of metastatic differentiated thyroid cancer.
    Carlo Chiesa, Maria Rita Castellani, Cecilia Vellani, Eva Orunesu, A. Negri, Raffaella Azzeroni, Francesca Botta, Marco Maccauro, Gianluca Aliberti, Ettore Cesare Seregni et al. · 2009 · PubMed
  143. Modified Radical Neck Dissection for Differentiated Thyroid Cancer: Operative Technique
    Shinya Uchino, Shiro Noguchi, Hiroyuki Yamashita, Shin Watanabe · 2004 · World Journal of Surgery
  144. Cystic change in thyroid carcinoma: Prevalence and estimated volume in 360 carcinomas
    Tara L. Henrichsen, Carl C. Reading, J. William Charboneau, Daniel J. Donovan, Thomas J. Sebo, IAN D. HAY · 2010 · Journal of Clinical Ultrasound
  145. Evaluation and Treatment of Aerodigestive Tract Invasion by Well-Differentiated Thyroid Carcinoma
    Judith Czaja McCaffrey · 2000 · Cancer Control
  146. The Importance of Pre- and Postoperative Laryngeal Examination for Thyroid Surgery
    Gregory William Randolph · 2010 · Thyroid
  147. Is there a role for radiation therapy in the management of hürthle cell carcinoma?
    Robert L. Foote, Paul D. Brown, Yolanda I. Garces, Bryan McIver, Jan L. Kasperbauer · 2003 · International Journal of Radiation Oncology*Biology*Physics
  148. Development of a clinical decision model for thyroid nodules
    Alexander Stojadinovic, George Earl Peoples, Steven K. Libutti, Leonard R. Henry, John S. Eberhardt, Robin S Howard, David Gur, Eric Andrew Elster, Aviram Nissan · 2009 · BMC Surgery
  149. The impact of initial surgical management on outcome in young patients with differentiated thyroid cancer
    Daniel K. Robie, Catherine Dinauer, Robert Michael Tuttle, David T. Ward, Robert Parry, Donald R McClellan, Rita L. Svec, Carol Adair, Gary L. Francis · 1998 · Journal of Pediatric Surgery
  150. The Cytological, Clinical, and Pathological Features of the Cribriform-Morular Variant of Papillary Thyroid Carcinoma and Mutation Analysis of CTNNB1 and BRAF Genes
    Chan Kwon Jung, Yeong Jin Choi, Kyo Young Lee, Ja Seong Bae, Hyung Jin Kim, Seung Kew Yoon, Young‐Ik Son, Jae Hoon Chung, Young Lyun Oh · 2009 · Thyroid
  151. 10.1007/b97251
    2008 · CrossRef Listing of Deleted DOIs
  152. Autoimmune Thyroid Disease: A Risk Factor for Thyroid Cancer
    Ghobad Azizi, Carl D. Malchoff · 2010 · Endocrine Practice
  153. Impact of timing on completion thyroidectomy for thyroid cancer
    Mona Poh-Choo Tan, Gaurav Agarwal, T. S. Reeve, Bruce H. Barraclough, Leigh Delbridge · 2002 · British journal of surgery
  154. Lessons from Mouse Models of Thyroid Cancer
    Caroline S. Kim, Xuguang Zhu · 2009 · Thyroid
  155. The Role of MR Imaging in Detecting Nodal Disease in Thyroidectomy Patients with Rising Thyroglobulin Levels
    Summer L. Kaplan, S. J. Mandel, R. Muller, Zafar Haleem Baloch, E.R. Thaler, Laurie A. Loevner · 2008 · American Journal of Neuroradiology
  156. Detection of Residual and Recurrent Thyroid Cancer by Radionuclide Imaging
    Harry R. Maxon · 1999 · Thyroid
  157. Clinical Experience with Recombinant Human Thyrotrophin (rhTSH) in the Management of Patients with Differentiated Thyroid Cancer
    Giuliano Mariani, Marco Ferdeghini, Carla Augeri, Giuseppe Villa, Gioconda Z. Taddei, Giovanni Scopinarô, Giuseppe Boni, Lisa Bodei, C Rabitti, Ettore Molinari et al. · 2000 · Cancer Biotherapy and Radiopharmaceuticals
  158. THYROGLOBULIN OF VARYING MOLECULAR SIZES WITH DIFFERENT DISAPPEARANCE RATES IN PLASMA FOLLOWING SUBTOTAL THYROIDECTOMY
    Ulla Feldt‐Rasmussen, P H Petersen, Hans Jørgen Nielsen, John Date, Charlotte Madsen · 1978 · Clinical Endocrinology
  159. Medullary Thyroid Carcinoma
    Ana O. Hoff, Paulo M. Hoff · 2007 · Hematology/Oncology Clinics of North America
  160. Preparation for radioactive iodine administration in differentiated thyroid cancer patients
    Yair Liel · 2002 · Clinical Endocrinology
  161. Total versus subtotal thyroidectomy. Arguments, approaches, and recommendations.
    Michael Friedman, Bernard L. Pacella · 1990 · PubMed
  162. The management of advanced thyroid cancer
    P. Wilson, Barbara-Ann M. Millar, James D. Brierley · 2004 · Clinical Oncology
  163. Comparison between ethanol sclerotherapy and emptying with injection of saline in treatment of thyroid cysts
    A. Antonelli, Alessandro Campatelli, A. Vito, BALDASSARE ALBERTI, V. Baldi, Giulio Salvioni, Pupah Fallahi, L. Baschieril · 1994 · Journal of Molecular Medicine
  164. Diagnostic accuracy of 131I scanning with recombinant human thyrotropin versus thyroid hormone withdrawal in a patient with metastatic thyroid carcinoma and hypopituitarism.
    Matthew David Ringel, Paul W. Ladenson · 1996 · The Journal of Clinical Endocrinology & Metabolism
  165. Postsurgery serum thyroglobulin disappearance kinetic in patients with differentiated thyroid carcinoma
    Luca Giovanella, Luca Ceriani, Marco Maffioli · 2009 · Head & Neck
  166. Proceedings: Effect of a low iodine diet on 131-I therapy in follicular thyroid carcinomata.
    B. M. Goslings · 1975 · PubMed
  167. Is a five-category reporting scheme for thyroid fine needle aspiration cytology accurate? Experience of over 18 000 FNAs reported at the same institution during 1998-2007
    Simonetta Piana, Andrea Frasoldati, Michele Ferrari · 2010 · Cytopathology
  168. Esophageal Invasion by Thyroid Carcinomas: Prediction Using Magnetic Resonance Imaging
    Jichen Wang, Shodayu Takashima, Tsuyoshi Matsushita, Fumiyoshi Takayama, Tetsuro Kobayashi, Masumi Kadoya · 2003 · Journal of Computer Assisted Tomography
  169. Differentiated Thyroid Carcinoma in Children and Young Adults: Evaluation of Response to Treatment
    Nir Hod, Philippe Hagag, Michal Baumer, Judith Sandbank, Tifha Horne · 2005 · Clinical Nuclear Medicine
  170. Pseudomonas aeruginosa bacteremia in patients with neoplastic disease
    Louis S. Fishman, Donald Armstrong · 1972 · Cancer
  171. Children with Differentiated Thyroid Cancer Achieve Adequate Hyperthyrotropinemia within 14 Days of Levothyroxine Withdrawal
    Wichert J. Kuijt, Stephen A. Huang · 2005 · The Journal of Clinical Endocrinology & Metabolism
  172. Usefulness of Recombinant Human Thyrotropin in the Radiometabolic Treatment of Selected Patients with Thyroid Cancer
    Gabriella Pellegriti, Claudia Scollo, Dario Giuffrida, Riccardo Vigneri, Sebastiano Squatrito, VINCENZO PEZZINO · 2001 · Thyroid
  173. Approach to the Patient with a Positive Serum Thyroglobulin and a Negative Radioiodine Scan after Initial Therapy for Differentiated Thyroid Cancer
    Richard T. Kloos · 2008 · The Journal of Clinical Endocrinology & Metabolism
  174. Serial TSH determination after T3 withdrawal or thyroidectomy in the therapy of thyroid carcinoma.
    S.V. Hilts, Dorothea E. Hellman, J Anderson, J.M. Woolfenden, J. Van Antwerp, Dennis D. Patton · 1979 · PubMed
  175. Radiopharmacokinetics of Radioiodine in the Parotid Glands After the Administration of Lemon Juice
    Douglas Van Nostrand, Varalakshmi V. Bandaru, Shyam P. Chennupati, Jason A. Wexler, Kanchan Kulkarni, Frank Atkins, Mihriye Mete, Gurudev Gadwale · 2010 · Thyroid
  176. Factors That Predict Malignant Thyroid Lesions When Fine-Needle Aspiration Is “Suspicious for Follicular Neoplasm”
    Richard T. Schlinkert, Jon A. van Heerden, John R. Goellner · 1997 · Mayo Clinic Proceedings
  177. Familial nonmedullary thyroid carcinoma—clinical relevance and prognosis. A European multicenter study
    Andreas Hillenbrand, J E Varhaug, Michael Brauckhoff et al. · 2010 · Langenbeck s Archives of Surgery
  178. Ultrasonographic characteristics as a criterion for repeat cytology in benign thyroid nodules
    Pedro Weslley Rosário, Saulo Purisch · 2010 · Arquivos Brasileiros de Endocrinologia & Metabologia
  179. Papillary thyroid carcinoma: MR diagnosis of lymph node metastasis.
    Shodayu Takashima, Shusuke Sone, Fumiyoshi Takayama, Qian Wang, Tetsuro Kobayashi, Arata Horii, Junichi Yoshida · 1998 · PubMed Central
  180. Total-body scintigraphy with thallium-201 and iodine-131 in the follow-up of differentiated thyroid cancer.
    JOSE MANUEL CARRIL, R. Quirce, Justo Serrano, Ignacio Banzo, Julio Francisco Jiménez-Bonilla, Olga Tabuenca, R Gómez Barquín · 1997 · PubMed
  181. FN1, GALE, MET, and QPCT overexpression in papillary thyroid carcinoma: Molecular analysis using frozen tissue and routine fine‐needle aspiration biopsy samples
    Cristina Aparecida Troques da Silveira Mitteldorf, Juliana Moreira de Sousa-Canavez, Kátia Ramos Moreira Leite · 2010 · Diagnostic Cytopathology
  182. Are there any specific ultrasound findings of nodular hyperplasia (“leave me alone” lesion) to differentiate it from follicular adenoma?
    Won‐Jin Moon, Hyon Joo Kwag, Dong-Gyu Na · 2009 · Acta Radiologica
  183. Recombinant human thyroid-stimulating hormone (rhTSH) in the radioablation of well-differentiated thyroid cancer: preliminary therapeutic experience.
    Petros Perros · 1999 · PubMed
  184. Measurement of thyroglobulin mRNA in peripheral blood as an adjunctive test for monitoring thyroid cancer
    Dimitris K Grammatopoulos, Y. Elliott, S C Smith, I Brown, Richard Grieve, E. W. Hillhouse, Michael A. Levine, Matthew David Ringel · 2003 · Molecular Pathology
  185. Prognostic Impact of Extrathyroid Extension and Clinical Lymph Node Metastasis in Papillary Thyroid Carcinoma Depend on Carcinoma Size
    Mitsuhiro Fukushima, Yasuhiro Ito, Mitsuyoshi Hirokawa, Akihiro Miya, Kazuo Shimizu, Akira Miyauchi · 2010 · World Journal of Surgery
  186. Utility of the Radioiodine Whole-Body Retention at 48 Hours for Modifying Empiric Activity of 131-Iodine for the Treatment of Metastatic Well-Differentiated Thyroid Carcinoma
    Douglas Van Nostrand, Frank Atkins, Shari Moreau, Martha Aiken, Kanchan Kulkarni, Jingshu S. Wu, Kenneth Dale Burman, Leonard Wartofsky · 2009 · Thyroid
  187. Long-term course and predictive factors of elevated serum thyroglobulin and negative diagnostic radioiodine whole body scan in differentiated thyroid cancer
    Ali Saeed Alzahrani, Gamal Mohamed, A. Al Shammary, Saleh A. Aldasouqi, Suzan Abdel Salam, Mohamed M. Shoukri · 2005 · Journal of Endocrinological Investigation
  188. Sentinel Lymph Node Biopsy for Papillary Thyroid Cancer: 12 Years of Experience at a Single Institution
    Deborah K. Cunningham, Katherine A. Yao, Roderick R. Turner · 2010 · Annals of Surgical Oncology
  189. Preparation of patients with thyroid cancer for 131I scintigraphy or therapy by 1-3 weeks of thyroxine discontinuation.
    Perry W. Grigsby, Barry Alan Siegel, Simon V. Bekker, William E. Clutter, Jeffrey F. Moley · 2004 · PubMed
  190. Comparison of I-123 and I-131 for Whole-Body Imaging After Stimulation by Recombinant Human Thyrotropin
    GREGORY S. ANDERSON, Stephanie A. Fish, Khozaim Nakhoda, Hongming Zhuang, Abass A. Alavi, Susan J. Mandel · 2003 · Clinical Nuclear Medicine
  191. Radioiodine Treatment of Thyroid Cancer with the Aid of Recombinant Human Thyrotropin
    Michael L. Adler, Homer A. Macapinlac, Richard J. Robbins · 1998 · Endocrine Practice
  192. Recurrent laryngeal nerve paralysis in patients with papillary thyroid carcinomas: evaluation and management of resulting vocal dysfunction
    Jong‐Lyel Roh, Yeo‐Hoon Yoon, Chan Il Park · 2008 · The American Journal of Surgery
  193. Levothyroxine Suppression of Thyroglobulin in Patients with Differentiated Thyroid Carcinoma1
    Pei‐Wen Wang, Shan‐Tair Wang, Rue‐Tsuan Liu, Wen-Yen Chien, Shih‐Chen Tung, Yung-Chuan Lu, Hue-Yong Chen, Chiang-Hsuan Lee · 1999 · The Journal of Clinical Endocrinology & Metabolism
  194. Thyroid tumor marker genomics and proteomics: Diagnostic and clinical implications
    Angelo Carpi, Jeffrey Ian Mechanick, Sven Saussez, Andrea Nicolini · 2010 · Journal of Cellular Physiology
  195. Treatment of iodine-negative thyroglobulin-positive thyroid cancer: differences in outcome in patients with macrometastases and patients with micrometastases
    Levent Kabasakal, Nalan Alan Selçuk, Hojjet Shafipour, Özlem Özmen, Çetin Önsel, İlhami Uslu · 2004 · European Journal of Nuclear Medicine and Molecular Imaging
  196. L‐T<sub>3</sub> preparation for whole‐body scintigraphy: a randomized‐controlled trial
    Leboeuf, Rébecca, Perron, Patrice, Carpentier, André C., Verreault, Jean, Langlois, Marie‐France · 2007 · Clinical Endocrinology
  197. Treatment of Scan-Negative, Thyroglobulin-Positive Metastatic Thyroid Cancer Using Radioiodine 131I and Recombinant Human Thyroid Stimulating Hormone
    A. Z. Rudavsky · 1997 · The Journal of Clinical Endocrinology & Metabolism
  198. Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation.
    Barbara Salvatore, Gaetano Paone, Michele Klain, Giovanni Storto, Emanuele Nicolai, Domenico D’Amico, Anna Maria Della Morte, Leonardo Pace, Marco Salvatore · 2008 · PubMed
  199. Gonadal damage from 131I therapy for thyroid cancer
    Ernest L. Mazzaferri · 2002 · Clinical Endocrinology
  200. Bone mineral density and bone fracture in male patients receiving long-term suppressive levothyroxine treatment for differentiated thyroid carcinoma
    Reverter, Jordi L., Colomé, Eulàlia, Holgado, Susana, Aguilera, Eva, Soldevila, Berta, Mateo, Lourdes, Sanmartí, Anna · 2010 · Endocrine